Literature DB >> 30337360

Low serum haptoglobin and blood films suggest intravascular hemolysis contributes to severe anemia in hereditary hemorrhagic telangiectasia.

Lieze Thielemans1, D Mark Layton2, Claire L Shovlin3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30337360      PMCID： PMC6442977          DOI： 10.3324/haematol.2018.205682

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  14 in total

Review 1.  Iron deficiency anaemia.

Authors:  Anthony Lopez; Patrice Cacoub; Iain C Macdougall; Laurent Peyrin-Biroulet
Journal:  Lancet       Date:  2015-08-24       Impact factor: 79.321

2.  Nasal closure for severe hereditary haemorrhagic telangiectasia in 100 patients. The Lund modification of the Young's procedure: a 22-year experience.

Authors:  V J Lund; Y Darby; J Rimmer; M Amin; S Husain
Journal:  Rhinology       Date:  2017-06-01       Impact factor: 3.681

3.  Gastrointestinal bleeding in patients with hereditary hemorrhagic telangiectasia.

Authors:  A D Kjeldsen; J Kjeldsen
Journal:  Am J Gastroenterol       Date:  2000-02       Impact factor: 10.864

4.  Ultrastructure and three-dimensional organization of the telangiectases of hereditary hemorrhagic telangiectasia.

Authors:  I M Braverman; A Keh; B S Jacobson
Journal:  J Invest Dermatol       Date:  1990-10       Impact factor: 8.551

5.  Severe hypophosphatemia: a rare cause of intravascular hemolysis.

Authors:  Jennifer D Melvin; Raymond G Watts
Journal:  Am J Hematol       Date:  2002-03       Impact factor: 10.047

6.  An epistaxis severity score for hereditary hemorrhagic telangiectasia.

Authors:  Jeffrey B Hoag; Peter Terry; Sally Mitchell; Douglas Reh; Christian A Merlo
Journal:  Laryngoscope       Date:  2010-04       Impact factor: 3.325

7.  Molecular characterization of hemoglobin D Punjab traits and clinical-hematological profile of the patients.

Authors:  Sanjay Pandey; Rahasya Mani Mishra; Sweta Pandey; Vineet Shah; Renu Saxena
Journal:  Sao Paulo Med J       Date:  2012       Impact factor: 1.044

8.  Hemorrhage-adjusted iron requirements, hematinics and hepcidin define hereditary hemorrhagic telangiectasia as a model of hemorrhagic iron deficiency.

Authors:  Helen Finnamore; James Le Couteur; Mary Hickson; Mark Busbridge; Kevin Whelan; Claire L Shovlin
Journal:  PLoS One       Date:  2013-10-16       Impact factor: 3.240

9.  Can Iron Treatments Aggravate Epistaxis in Some Patients With Hereditary Hemorrhagic Telangiectasia?

Authors:  Claire L Shovlin; Clare Gilson; Mark Busbridge; Dilip Patel; Chenyang Shi; Roberto Dina; F Naziya Abdulla; Iman Awan
Journal:  Laryngoscope       Date:  2016-04-23       Impact factor: 3.325

10.  Circulatory contributors to the phenotype in hereditary hemorrhagic telangiectasia.

Authors:  Claire L Shovlin
Journal:  Front Genet       Date:  2015-04-09       Impact factor: 4.599
View more
  4 in total

1.  Synergistic effects of ADAMTS13 deficiency and complement activation in pathogenesis of thrombotic microangiopathy.

Authors:  Liang Zheng; Di Zhang; Wenjing Cao; Wen-Chao Song; X Long Zheng
Journal:  Blood       Date:  2019-08-13       Impact factor: 22.113

2.  Mutational and phenotypic characterization of hereditary hemorrhagic telangiectasia.

Authors:  Claire L Shovlin; Ilenia Simeoni; Kate Downes; Zoe C Frazer; Karyn Megy; Maria E Bernabeu-Herrero; Abigail Shurr; Jennifer Brimley; Dilipkumar Patel; Loren Kell; Jonathan Stephens; Isobel G Turbin; Micheala A Aldred; Christopher J Penkett; Willem H Ouwehand; Luca Jovine; Ernest Turro
Journal:  Blood       Date:  2020-10-22       Impact factor: 22.113

3.  Whole genome sequences discriminate hereditary hemorrhagic telangiectasia phenotypes by non-HHT deleterious DNA variation.

Authors:  Katie E Joyce; Ebun Onabanjo; Sheila Brownlow; Fadumo Nur; Kike Olupona; Kehinde Fakayode; Manveer Sroya; Geraldine A Thomas; Teena Ferguson; Julian Redhead; Carolyn M Millar; Nichola Cooper; D Mark Layton; Freya Boardman-Pretty; Mark J Caulfield; Claire L Shovlin
Journal:  Blood Adv       Date:  2022-07-12

4.  Safety of thalidomide and bevacizumab in patients with hereditary hemorrhagic telangiectasia.

Authors:  Elisabetta Buscarini; Luisa Maria Botella; Urban Geisthoff; Anette D Kjeldsen; Hans Jurgen Mager; Fabio Pagella; Patrizia Suppressa; Roberto Zarrabeitia; Sophie Dupuis-Girod; Claire L Shovlin
Journal:  Orphanet J Rare Dis       Date:  2019-02-04       Impact factor: 4.123
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.